SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy

SANG 4.995

-1.0%

Dec 23 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nelli who wrote (59)	1/22/1998 7:16:00 PM
From: nelli	Read Replies (1) of 184

from Motley Fool Organ transplant therapies company Sangstat Medical (Nasdaq:SANG - news) was felled for $6 1/2 to $26 after Hambrecht & Quist lowered its 1998 EPS estimate from $1.20 to a loss of $0.36 per share. H&Q's analyst said she was too aggressive with estimates in light of recent product delays.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next